Post on 07-Oct-2014
10.5731/pdajpst.2011.00823Access the most recent version at doi: 599-61165, 2011 PDA J Pharm Sci and Tech
Jim Skrine Minute Mouse Virus
−−A Biotech Production Facility Contamination Case Study
on February 1, 2012journal.pda.orgDownloaded from
CONFERENCE PROCEEDINGProceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection andMitigation Strategies Workshop in Bethesda, MD, USA; December 1–3, 2010Guest Editors: Arifa Khan (Bethesda, MD), Patricia Hughes (Bethesda, MD) andMichael Wiebe (San Francisco, CA)
A Biotech Production Facility Contamination CaseStudy—Minute Mouse VirusJIM SKRINE
Executive Director, North America, Operations Quality, Amgen ©PDA, Inc. 2011
Jskrine@amgen.com
doi: 10.5731/pdajpst.2011.00823
599Vol. 65, No. 6, November–December 2011
on February 1, 2012journal.pda.orgDownloaded from
600 PDA Journal of Pharmaceutical Science and Technology
on February 1, 2012journal.pda.orgDownloaded from
601Vol. 65, No. 6, November–December 2011
on February 1, 2012journal.pda.orgDownloaded from
602 PDA Journal of Pharmaceutical Science and Technology
on February 1, 2012journal.pda.orgDownloaded from
603Vol. 65, No. 6, November–December 2011
on February 1, 2012journal.pda.orgDownloaded from
604 PDA Journal of Pharmaceutical Science and Technology
on February 1, 2012journal.pda.orgDownloaded from
605Vol. 65, No. 6, November–December 2011
on February 1, 2012journal.pda.orgDownloaded from
606 PDA Journal of Pharmaceutical Science and Technology
on February 1, 2012journal.pda.orgDownloaded from
607Vol. 65, No. 6, November–December 2011
on February 1, 2012journal.pda.orgDownloaded from
608 PDA Journal of Pharmaceutical Science and Technology
on February 1, 2012journal.pda.orgDownloaded from
609Vol. 65, No. 6, November–December 2011
on February 1, 2012journal.pda.orgDownloaded from
610 PDA Journal of Pharmaceutical Science and Technology
on February 1, 2012journal.pda.orgDownloaded from
611Vol. 65, No. 6, November–December 2011
on February 1, 2012journal.pda.orgDownloaded from
Authorized User or for the use by or distribution to other Authorized Users·Make a reasonable number of photocopies of a printed article for the individual use of an·Print individual articles from the PDA Journal for the individual use of an Authorized User ·Assemble and distribute links that point to the PDA Journal·Download a single article for the individual use of an Authorized User·Search and view the content of the PDA Journal permitted to do the following:Technology (the PDA Journal) is a PDA Member in good standing. Authorized Users are An Authorized User of the electronic PDA Journal of Pharmaceutical Science and
copyright information or notice contained in the PDA Journal·Delete or remove in any form or format, including on a printed article or photocopy, anytext or graphics·Make any edits or derivative works with respect to any portion of the PDA Journal including any·Alter, modify, repackage or adapt any portion of the PDA Journaldistribution of materials in any form, or any substantially similar commercial purpose·Use or copy the PDA Journal for document delivery, fee-for-service use, or bulk reproduction orJournal or its content·Sell, re-sell, rent, lease, license, sublicense, assign or otherwise transfer the use of the PDAof the PDA Journal ·Use robots or intelligent agents to access, search and/or systematically download any portion·Create a searchable archive of any portion of the PDA JournalJournal·Transmit electronically, via e-mail or any other file transfer protocols, any portion of the PDAor in any form of online publications·Post articles from the PDA Journal on Web sites, either available on the Internet or an Intranet,than an Authorized User· Display or otherwise make any information from the PDA Journal available to anyone otherPDA Journal·Except as mentioned above, allow anyone other than an Authorized User to use or access the Authorized Users are not permitted to do the following:
on February 1, 2012journal.pda.orgDownloaded from